THOMAS RICHARDSON: Open Payments
NPI 1528099355 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 24 payments from 7 companies in 2025. Trend: 2023 $588 · 2024 $503 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $144 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| ABBVIE INC. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Almatica Pharma LLC | 1 | $16 |
Products named: INGREZZA, COBENFY, VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY, SPRAVATO.
Industry payments across PA — which companies pay providers there.
